DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 539, Issue 1-2, 2003, Pages 1-8

  Liu, Xiaoju ^a,b   Zhao, Jin ^a,c   Zheng, Rongliang ^a  

^a LANZHOU UNIVERSITY   (China)

^b First Affil Hosp Lanzhou Med C   (China)

^c Med Coll Northwest Minorities U   (China)

Author keywords

DNA damage; Malignant pleural effusion; Melatonin; Repair; Total antioxidant capacity; Tumor associated lymphocytes

Indexed keywords

DNA; MELATONIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; BREAST CARCINOMA; CELL ASSAY; CLINICAL ARTICLE; COMET ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MONONUCLEAR CELL; PLEURA EFFUSION; PRIORITY JOURNAL; SUPERNATANT; THYROID CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0042978600     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(03)00112-8     Document Type: Article

References (47)

1. Sies H., de Groot H. Role of reactive oxygen species in cell toxicity. Toxicol. Lett. 64:1992;547-551.
2. Aas P.A., Otterlei M., Falnes P.O., Vagbc C.B., Skorpen F., Akbari M., Sundheim O., Bjoras M., Slupphaug G., Seeberg E., Krokan H.E. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature. 421:2003;859-863.
3. Das U.N. A radical approach to cancer. Med. Sci. Monit. 8(4):2002;79-92.
4. Ames B.N. Micronutrients prevent cancer and delay aging. Toxicol. Lett. 102/103:1998;5-18.
5. Cao G., Prior R.L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem. 44:1998;1309-1315.
6. Leinonen S.J., Ahonen J.-P., Lonnrot K., Jehkonen M., Dastidar P., Molnar G., Alho H. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. 31(1):2000;2266-2278.
7. Mantovani G., Maccio A., Pisano M., Versace R., Lai P., Esu S., Massa E., Ghiani M., Dessi D., Melis G.B., Giacco G.S.D. Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines. Int. J. Cancer. 71:1997;724-731.
8. Chen Y.M., Yang W.K., Ting C.C., Tsai W.Y., Yang D.M., Peng J.W., Perng R.P. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions lung cancer patients. Chest. 112:1997;960-966.
9. Hiramatus K., Yanagawa H., Haku T., Sone S. Generation of killer activity by interleukin-12 of mononuclear cells in malignant pleural effusions due to lung cancer. Cancer Immunol. Immunother. 46:1998;1-6.
10. Zieba M., Suwalski M., Kwiatkowska S., Piasecka G., Grzelewska-Rzymowska I., Stolarel R., Nowak D. Comparison of hydrogen peroxide generation and the content of lipid peroxidation products in lung cancer tissue and pulmonary parenchyma. Respir. Med. 94:2000;800-805.
11. Lee M., Yea S.S. Hydrogen peroxide inhibits the immune response to lipopolysaccharide by attenuating signaling through c-Jun N-terminal kinase and p38 associated with protein kinase C. Immunopharmacology. 48:2000;165-172.
12. Orr F.W., Warner D.J. Effects of systemic complement activation and neutrophil-mediated pulmonary injury on the retention and metastases of circulating cancer cells in mouse lung. Lab. Invest. 62:1990;331-338.
13. Monte M., Davel L.E., de-Lustig E.S. Inhibition of lymphocyte-induced angiogenesis by free radical scavengers. Free Radic. Biol. Med. 17:1994;259-266.
14. Shaughnessy S.G., Buchanan M.R., Turple S., Richardson M., Orr F.W. Walker carcinoma cells damage endothelial cells by the generation of reactive oxygen species. Am. J. Pathol. 134:1989;789-796.
15. Reiter R.J. The pineal gland and its hormones in the control of reproduction in mammals. Endocr. Rev. 1:1980;109-131.
16. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
17. Reiter R.J. The ageing pineal gland and its physiological consequences. Bioessays. 14:1992;169-175.
18. Vijayalaxmi, R.J. Reiter, M.L. Meltz, Melatonin protects human blood lymphocytes from radiation-induced chromosome damage, Mutat. Res. 346 (1995) 23-31.
19. Vijayalaxmi, R.J. Reiter, T.S. Herman, M.L. Meltz, Melatonin and radioprotection from genetic damage: in vivo or in vitro studies with human volunteers, Mutat. Res. 371 (1996) 221-228.
20. Lissoni P., Barni S., Tancini G., Fossati V., Frigerio F. Pineal-opioid system interaction in the control of immunoinflammatory responses. Ann. NY Acad. Sci. 741:1994;191-196.
21. Lissoni P., Bolis S., Brivio F., Fumagalli L. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies. Anticancer Res. 20(3B):2000;2103-2105.
22. Jajte J., Zmy'slony M., Palus J., Dziubaltowska E., Rajkowska E. Protective effect of melatonin against in vitro iron ions and 7 mT 50 Hz magnetic field-induced DNA damage in rat lymphocytes. Mutat. Res. 483:2001;57-64.
23. Vijayalaxmi, R.J. Reiter, T.S. Herman, M.L. Meltz, Melatonin reduces gamma radiation induced primary DNA damage in human blood lymphocytes, Mutat. Res. 397 (1998) 203-208.
24. 3. Free Radic. Biol. Med. 26:1999;1531-1537.
25. Cuzzocrea S., Tan D.X., Costantino G., Mazzon E., Caputi A.P., Reiter R.J. The protective role of endogenous melatonin in carrageenan-induced pleurisy in the rat. FASEB J. 13:1999;1930-1938.
26. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
27. Pouget J.P., Douki T., Richard M.J., Cadet J. DNA damage induced in cells by gamma and UVA radiations: calibrated comet assay with HPLC/GC-MS and HPLC-EC measurements. Chem. Res. Toxicol. 13:2000;541-549.
28. Burner S.D., Norman D.P.G., Verdine G.L. Structure basis for recognition and repair of the endogenous 8-oxoguanine in DNA. Nature. 403:2000;859-866.
29. J. Cadet, M. Bardet, M. Berger, A.G. Bourdat, T. Douki, V. Duarte, S. Frelon, D. Gasparutto, A. Grand, J.P. Pouget, J.L. Ravanat, S. Sauvaigo, Oxidative damage to DNA: measurement and biological role, in: T. Yoshikawa, S. Toyokuni, Y. Yamamoto, Y. Naito (Eds.), Free Radical in Chemistry, Biology and Medicine, OICA, London, 2000, pp. 45-57.
30. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239:1996;70-76.
31. Liu G.A., Jin F.L., Zheng R.L. Protection against damaged DNA in single cell by polyphenols. Die Pharmazie. 57(12):2002;852-854.
32. Everett S.M., White K.L.M., Schorah C.J., Calvert R.J., Skinner C., Miller D., Axon A.R.T. In vivo DNA damage in gastric epithelial cells. Mutat. Res. 468:2000;73-85.
33. Hack V., Schmid D., Breitkreutz R., Stahl-Hennig C., Drings P., Kinscherf R., Taut F., Holm E., Droge W. Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB J. 11:1997;84-92.
34. Guven M., Ozturk B., Sayal A., Ozeturk A., Ulutin T. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis. Cancer Biochem. Biophys. 17(1-2):1999;155-162.
35. Hristozov D., Gadjeva V., Vlaykova T., Dimitrov G. Evaluation of oxidative stress in patients with cancer. Arch. Physiol. Biochem. 109(4):2001;331-336.
36. Tan D.T., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:1993;57-60.
37. Reiter R.J. Antioxidant action of melatonin. Adv. Pharmacol. 38:1997;103-117.
38. Gilad E., Cuzzocrea S., Zingarelli B., Salzman A.L., Szaba C. Melatonin is a scavenger of peroxynitrite. Life Sci. 60:1997;PL169-PL174.
39. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than Vitamin E. Life Sci. 55:1994;PL271-PL276.
40. Reiter R.J., Tan D.X., Sainz R.M., Mayo J.C., Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 54:2002;1299-1321.
41. Burrows C.J., Muller J.G. Oxidative nucleobase modifications leading to strand scission. Chem. Rev. 98:1998;1109-1151.
42. Steenken S., Jovanovic S. How easily oxidizable is DNA? One-electron reduction potentials of adenosine and guanosine radicals in aqueous solution. J. Am. Chem. Soc. 119:1997;617-618.
43. Pryor W., Squadrito G. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with the superoxide anion. Am. J. Physiol. Lung Cell Mol. Physiol. 268:1995;L699-L722.
44. Bandyopadhyay D., Bandyopadhyay A., Das P.K., Reiter R.J. Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage. J. Pineal Res. 33:2002;1-7.
45. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56:1998;359-384.
46. Tan D.X., Reiter R.J., Chen L.D., Poeggeler B., Manchester L.C., Barlowwalden L.R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis. 15:1994;215-218.
47. Reiter R.J., Guerrero J.M., Garcia J.J., Acuna-Castroviejo D. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann. NY Acad. Sci. 854:1998;410-424.